Similarly, Scheeren et al. demonstrated that the TLR2/MyD88 signaling pathway plays a cell-intrinsic role in the function of mammary and intestinal stem cells, and it promotes the development of intestinal and ER negative breast cancers in preclinical models [46]. The gene discussed is TLR2; the disease is breast cancer.